Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3475 of 3546 entries
View as:

A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT06261957 Org: User:
Start: 05/31/24 End: 09/24/25 Due: 09/24/26

Study Of Bupropion SR (323U66) In Patients With Major Depressive Disorder In Japan

Phase: N/A Priority: Normal
NCT ID: NCT00330616 Org: User:
Start: 05/31/06 End: 11/30/07 Due: 11/30/08

RELVAR® 100 ELLIPTA® Special Drug Use Investigation (COPD, Long-term)

Phase: N/A Priority: Normal
NCT ID: NCT03219255 Org: User:
Start: 08/30/17 End: 03/30/21 Due: 03/30/22

Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Healthy Vietnamese Children

Phase: N/A Priority: Normal
NCT ID: NCT01988857 Org: User:
Start: 02/22/14 End: 05/10/14 Due: 05/10/15

Effect Of Talnetant Versus Risperidone Versus Placebo On Psychotic Symptoms In Schizophrenic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00300963 Org: User:
Start: 12/31/04 End: 10/31/05 Due: 10/31/06

Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults

Phase: N/A Priority: Normal
NCT ID: NCT00449436 Org: User:
Start: 01/10/05 End: 12/13/07 Due: 12/13/08

Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib

Phase: N/A Priority: Normal
NCT ID: NCT00356564 Org: User:
Start: 07/31/06 End: 12/31/06 Due: 12/31/07

Immunogenicity and Safety of GSK Biologicals' HPV Vaccine 580299 in Healthy Japanese Females 10-15 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT00492544 Org: User:
Start: 07/02/07 End: 03/28/08 Due: 03/28/09

Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342

Phase: N/A Priority: Normal
NCT ID: NCT01669096 Org: User:
Start: 08/21/12 End: 05/24/13 Due: 05/24/14

A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK2816126 in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma, Transformed Follicular Lymphoma, Other Non-Hodgkin's Lymphomas, Solid Tumors and Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02082977 Org: User:
Start: 04/24/14 End: 06/20/17 Due: 06/20/18

Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00766090 Org: User:
Start: 10/31/08 End: 03/31/09 Due: 03/31/10

To Evaluate Real-World Effectiveness of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol (FF/UMEC/VI) in a Single Inhaler (Trelegy Ellipta) in Participants With Symptomatic COPD

Phase: N/A Priority: Normal
NCT ID: NCT05535972 Org: User:
Start: 10/14/22 End: 09/25/23 Due: 09/25/24

A Study to Estimate the Occurrence of Rotavirus Gastroenteritis in Children < 5 Years of Age, in Bulgaria and Latvia

Phase: N/A Priority: Normal
NCT ID: NCT01733849 Org: User:
Start: 12/31/12 End: 06/30/14 Due: 06/30/15

This Study is Randomised, Single Oral Dose Bioequivalence Study of Meloxicam GSK 15 MG Tablets.

Phase: N/A Priority: Normal
NCT ID: NCT01750931 Org: User:
Start: 09/12/13 End: 10/01/13 Due: 10/01/14

A 24-week Arterial Stiffness Study With Fluticasone Furoate/Vilanterol in COPD

Phase: N/A Priority: Normal
NCT ID: NCT01336608 Org: User:
Start: 03/04/11 End: 11/04/14 Due: 11/04/15

Assessing the Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT02285777 Org: User:
Start: 12/01/14 End: 06/11/15 Due: 06/11/16

Meta-analysis of Efficacy of Topotecan

Phase: N/A Priority: Normal
NCT ID: NCT01160185 Org: User:
Start: 06/30/09 End: 07/31/09 Due: 07/31/10

A Study to Evaluate the Effect of Intravenous Zanamivir on Cardiac Conduction in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01353729 Org: User:
Start: 05/19/11 End: 08/02/11 Due: 08/02/12

Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00510874 Org: User:
Start: 07/28/07 End: 10/24/08 Due: 10/24/09

Immunogenicity and Safety of Meningococcal Vaccine GSK134612 Given as 1 or 2 Doses to Healthy 9-12 Months Old Toddlers.

Phase: N/A Priority: Normal
NCT ID: NCT00471081 Org: User:
Start: 07/05/07 End: 11/26/08 Due: 11/26/09

A Study to Evaluate the Effect of Antacid and Multivitamin and Mineral Tablet on the Study Drug GSK1349572

Phase: N/A Priority: Normal
NCT ID: NCT00858455 Org: User:
Start: 01/31/09 End: 03/31/09 Due: 03/31/10

Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00708552 Org: User:
Start: 07/04/08 End: 03/09/10 Due: 03/09/11

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the GlaxoSmithKline (GSK) Biologicals' Respiratory Syncytial Virus (RSV) Investigational Vaccine (GSK3003891A) in Healthy Pregnant Women and Infants Born to Vaccinated Mothers

Phase: N/A Priority: Normal
NCT ID: NCT03191383 Org: User:
Start: 07/11/17 End: 07/14/17 Due: 07/14/18

Combined Study - Phase 3b MenB Long Term Persistence in Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT02446743 Org: User:
Start: 11/17/15 End: 09/23/16 Due: 09/23/17

SB-773812 Administered In Adults With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00259870 Org: User:
Start: 09/30/05 End: 08/31/07 Due: 08/31/08